Viatris is headquartered in the United States, with three global centers in Pittsburgh, Pennsylvania, U.S., Shanghai, China, and Hyderabad, India. They operate approximately 40 manufacturing facilities, which produce complex dosage forms, injectables, oral solid doses, and active pharmaceutical ingredients. And maintain an industry-leading pipeline, composed of numerous complex generics, biosimilars and global key brands.

As they work to fully transition to the Viatris brand commercially and operationally around the world, you may continue to see both the Mylan and Upjohn names in certain markets.